Idera Pharmaceuticals, Inc. Announces Extension of Research Collaboration on Asthma and Allergy with Novartis Corporation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Idera Pharmaceuticals Inc. (AMEX: IDP), announced today that Novartis has decided to extend the term of the research phase of their collaboration by one year.